Recursion Pharmaceuticals Statistics

Total Valuation

BMV:RXRX has a market cap or net worth of MXN 33.35 billion. The enterprise value is 21.78 billion.

Market Cap	33.35B
Enterprise Value	21.78B

Important Dates

The last earnings date was Wednesday, February 25, 2026.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	521.95M
Shares Outstanding	n/a
Shares Change (YoY)	+63.18%
Shares Change (QoQ)	+17.84%
Owned by Insiders (%)	3.11%
Owned by Institutions (%)	63.41%
Float	510.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	24.80
PB Ratio	1.64
P/TBV Ratio	2.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.88
EV / Sales	16.77
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.20

Financial Position

The company has a current ratio of 5.50, with a Debt / Equity ratio of 0.07.

Current Ratio	5.50
Quick Ratio	5.20
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	-0.21
Interest Coverage	-358.08

Financial Efficiency

Return on equity (ROE) is -59.54% and return on invested capital (ROIC) is -34.44%.

Return on Equity (ROE)	-59.54%
Return on Assets (ROA)	-27.72%
Return on Invested Capital (ROIC)	-34.44%
Return on Capital Employed (ROCE)	-48.86%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	2.24M
Profits Per Employee	-19.35M
Employee Count	800
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	-2.45M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.02% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-61.02%
50-Day Moving Average	82.89
200-Day Moving Average	n/a
Relative Strength Index (RSI)	38.54
Average Volume (20 Days)	2,223

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.79

Income Statement

In the last 12 months, BMV:RXRX had revenue of MXN 1.34 billion and -11.61 billion in losses. Loss per share was -25.94.

Revenue	1.34B
Gross Profit	-8.49B
Operating Income	-11.67B
Pretax Income	-11.61B
Net Income	-11.61B
EBITDA	-10.16B
EBIT	-11.67B
Loss Per Share	-25.94

Full Income Statement

Balance Sheet

The company has 13.38 billion in cash and 1.40 billion in debt, with a net cash position of 11.98 billion.

Cash & Cash Equivalents	13.38B
Total Debt	1.40B
Net Cash	11.98B
Net Cash Per Share	n/a
Equity (Book Value)	20.36B
Book Value Per Share	38.55
Working Capital	11.97B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.69 billion and capital expenditures -116.46 million, giving a free cash flow of -6.81 billion.

Operating Cash Flow	-6.69B
Capital Expenditures	-116.46M
Free Cash Flow	-6.81B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-867.87%
Pretax Margin	-863.53%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BMV:RXRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-63.18%
Shareholder Yield	-63.18%
Earnings Yield	-34.81%
FCF Yield	-20.42%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BMV:RXRX has an Altman Z-Score of 1.34 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.34
Piotroski F-Score	3